Literature DB >> 15365084

Maturation matters: importance of maturation for antitumor immunity of dendritic cell vaccines.

Sylvia Adams, David O'Neill, Nina Bhardwaj.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15365084     DOI: 10.1200/JCO.2004.99.019

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1.

Authors:  Pooja Jain; Jaya Ahuja; Zafar K Khan; Saori Shimizu; Olimpia Meucci; Stephen R Jennings; Brian Wigdahl
Journal:  J Leukoc Biol       Date:  2007-04-18       Impact factor: 4.962

2.  Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients.

Authors:  Ruggero Ridolfi; Massimiliano Petrini; Laura Fiammenghi; Monica Stefanelli; Laura Ridolfi; Michela Ballardini; Giuseppe Migliori; Angela Riccobon
Journal:  J Transl Med       Date:  2006-08-16       Impact factor: 5.531

3.  Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.

Authors:  Kira Minkis; Daniel G Kavanagh; Galit Alter; Dusan Bogunovic; David O'Neill; Sylvia Adams; Anna Pavlick; Bruce D Walker; Mark A Brockman; Rajesh T Gandhi; Nina Bhardwaj
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

4.  Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.

Authors:  Sung Nam Park; Kyung Tae Noh; Young-Il Jeong; In Duk Jung; Hyun Kyu Kang; Gil Sun Cha; Su Jung Lee; Jong Keun Seo; Dae Hwan Kang; Tae-Ho Hwang; Eun Kyung Lee; Byungsuk Kwon; Yeong-Min Park
Journal:  Exp Mol Med       Date:  2013-02-08       Impact factor: 8.718

5.  A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.

Authors:  Erika M von Euw; María M Barrio; David Furman; Estrella M Levy; Michele Bianchini; Isabelle Peguillet; Olivier Lantz; Alejandra Vellice; Abraham Kohan; Matías Chacón; Cassian Yee; Rosa Wainstok; José Mordoh
Journal:  J Transl Med       Date:  2008-01-25       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.